Given the crucial role of TDRMT1 in the DNA damage response of cancer cells, we developed a potent inhibitor of TRDMT1 and showed that it sensitizes cancer cells to DNA-damaging agents, thereby opening a new avenue to targeting RNMTs in cancer therapy. This evidence concerns the gene TRDMT1 and cancer.